Could an Alzheimer's Drug Be Approved Monday?
June 06, 2021 at 19:00 PM EDT
Biotechnology sector-related exchange traded funds are in for a wild ride as Biogen (NasdaqGS: BIIB) is set to receive a verdict from the Food and Drug Administration on its Alzheimer’s drug.